Literature DB >> 16355450

Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract.

Xueli Wang1, Dongming Xing, Wei Wang, Hui Su, Jialin Tao, Lijun Du.   

Abstract

A rapid and simple high-performance liquid chromatographic method for determination of berberine in rat thalamus was described in this study. Thalamus samples were pretreated by protein precipitation with methanol and acetonitrile. Berberine was determined using a Hypersil C(18) column with an isocratic mobile phase of acetonitrile--0.05 M potassium dihydrogen phosphate (containing 0.5% triethylamine, pH 3.0) (30:70 v/v) and with UV detection at 265 nm. The lower limit of quantification for berberine in thalamus was 24 ng/ml, and the lowest concentration of berberine determined in rat thalamus samples was 47.5 ng/ml at 48 hours. The calibration curve for berberine was linear (r(2) = 0.9994) over the concentration range 24-6000 ng/ml. At this concentration range, the overall recoveries (91.20%-93.24%) for berberine were determined and the accuracy of the intra- and inter-day assays from rat thalamus were less than 6% RSD. Following intravenous administration of 10.2 mg/kg of Coptidis Rhizoma (CR) extract containing 3 mg/kg berberine into rats, the thalamus level of berberine increased rapidly (t(1/2alpha) = 1.93 hours), peaked at 2.48 hours with a concentration of 271 ng/g, and had a slow elimination rate (t(1/2beta) = 14.6 hours), which suggested that berberine might directly act on certain regions of the thalamus, have pharmacological effects on some cerebral dysfunctions, and be an active ingredient of huang lian jie du tang for the treatment of cerebral disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16355450     DOI: 10.1142/S0192415X05003557

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

Review 1.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

2.  Tissue distribution of berberine and its metabolites after oral administration in rats.

Authors:  Xiang-Shan Tan; Jing-Yi Ma; Ru Feng; Chao Ma; Wen-Jing Chen; Yu-Peng Sun; Jie Fu; Min Huang; Chi-Yu He; Jia-Wen Shou; Wen-Yi He; Yan Wang; Jian-Dong Jiang
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

3.  Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury.

Authors:  Chien-Cheng Chen; Tai-Ho Hung; Chao Yu Lee; Liang-Fei Wang; Chun-Hu Wu; Chia-Hua Ke; Szu-Fu Chen
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

4.  Berberine exerts antidepressant-like effects via regulating miR-34a-synaptotagmin1/Bcl-2 axis.

Authors:  Li-Tao Yi; Ji-Xiao Zhu; Shu-Qi Dong; Min Chen; Cheng-Fu Li
Journal:  Chin Herb Med       Date:  2020-12-01

5.  HybridSPE: A novel technique to reduce phospholipid-based matrix effect in LC-ESI-MS Bioanalysis.

Authors:  Shafeeque Ahmad; Harsh Kalra; Amit Gupta; Bharat Raut; Arshad Hussain; Md Akhlaquer Rahman
Journal:  J Pharm Bioallied Sci       Date:  2012-10

6.  Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model.

Authors:  Wenxiao Jiang; Wenjie Wei; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

7.  Proteomic profiling of the neurons in mice with depressive-like behavior induced by corticosterone and the regulation of berberine: pivotal sites of oxidative phosphorylation.

Authors:  Qin Gong; Xiao-Jin Yan; Fan Lei; Mu-Lan Wang; Lu-Ling He; Ying-Ying Luo; Hong-Wei Gao; Yu-Lin Feng; Shi-Lin Yang; Jun Li; Li-Jun Du
Journal:  Mol Brain       Date:  2019-12-30       Impact factor: 4.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.